Pharmacological evaluation of tannic acid–based chelation therapy in ferric citrate–supplemented rats
Tannic acid is recognised as a natural iron chelator; however, its in vivo applicability may be constrained by non-specific interactions with amino- and thiol-containing biomolecules, potentially altering its bioavailability, pharmacokinetics and pharmacodynamics. In the present study, several formulations of tannic acid (TA)–based chelators, including unmodified TA, oxidised TA (TAox), phenylalanine-combined TA (TAphe), lysine-combined TA (TAlys), or cysteine-combined TA (TAcys), were synthesized and evaluated for chelation therapy in ferric citrate–supplemented rats. Animals fed a ferric citrate–enriched diet for eight weeks, followed by an eight-week chelation regimen with distinct TA-based formulations, exhibited chelator-dependent alterations in hepatic iron accumulation and liver enzyme activity, without significant changes in reactive oxygen species (ROS) production or lipid peroxidation. Notably, TAlys exhibited the greatest reduction in hepatic iron, while TAcys exhibited the greatest attenuation of serum alanine aminotransferase (ALT) and alkaline phosphatase (ALP) activities. In plasma, selected chelation treatments, particularly TAphe, reduced plasma ROS levels without affecting systemic iron accumulation. In contrast, none of the TA-based chelation treatments produced statistically significant changes in brain iron levels or oxidative stress markers, although some trends in specific behavioral performance were observed. Collectively, these findings indicate that TA-based chelation therapy predominantly modulates iron homeostasis and function. Specific TA-based formulations may therefore represent promising candidates for further pharmacological development in targeted iron chelation and related therapeutic or nutraceutical applications.
Authors
- Jannarong Intakhad
- Chalermchai Pilapong (ORCID: https://orcid.org/0000-0002-9099-3979)
- Aiyarin Kittilukkana
Institutions
- Chiang Mai University (TH)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1038/s41598-026-78933-0
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00